# Yi‐Hsing Chen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yi-hsing-chen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,260 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 31 |
| i10-index | 74 |
| Last Known Institution | China Medical University |
| OpenAlex ID | https://openalex.org/A5102017113 |
| ORCID iD | 0000-0002-8135-9554 |
| Works | 198 |

## Researcher papers

- [Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy](https://scholariq.org/papers/kinetics-of-viral-loads-and-risk-of-hepatitis-b-virus-reactivation-in-hepatitis/)
- [Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial](https://scholariq.org/papers/malignancy-risk-with-tofacitinib-versus-tnf-inhibitors-in-rheumatoid-arthritis/)
- [Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study](https://scholariq.org/papers/hydroxychloroquine-reduces-risk-of-incident-diabetes-mellitus-in-lupus-patients/)
- [Heat-killed and live Lactobacillus reuteri GMNL-263 exhibit similar effects on improving metabolic functions in high-fat diet-induced obese rats](https://scholariq.org/papers/heat-killed-and-live-lactobacillus-reuteri-gmnl-263-exhibit-similar-effects-on/)
- [Significant associations of antidrug antibody levels with serum drug trough levels and therapeutic response of adalimumab and etanercept treatment in rheumatoid arthritis](https://scholariq.org/papers/significant-associations-of-antidrug-antibody-levels-with-serum-drug-trough/)
- [Brief Report: Validation of a Definition of Flare in Patients With Established Gout](https://scholariq.org/papers/brief-report-validation-of-a-definition-of-flare-in-patients-with-established/)
- [Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to conventional DMARDs: a randomised, double-blind, placebo-controlled phase III trial (RAJ3)](https://scholariq.org/papers/efficacy-and-safety-of-peficitinib-asp015k-in-patients-with-rheumatoid-arthritis/)
- [Reactivation of hepatitis B virus infection in patients with rheumatoid arthritis receiving tofacitinib: a real-world study](https://scholariq.org/papers/reactivation-of-hepatitis-b-virus-infection-in-patients-with-rheumatoid/)
- [EsaD, a Secretion Factor for the Ess Pathway in<i>Staphylococcus aureus</i>](https://scholariq.org/papers/esad-a-secretion-factor-for-the-ess-pathway-in-i-staphylococcus-aureus-i/)
- [Adult atopic dermatitis and exposure to air pollutants—a nationwide population-based study](https://scholariq.org/papers/adult-atopic-dermatitis-and-exposure-to-air-pollutants-a-nationwide-population/)
- [Renal Histopathology Associated With Kidney Failure and Mortality in Patients With Lupus Nephritis: A Long-Term Real-World Data Study](https://scholariq.org/papers/renal-histopathology-associated-with-kidney-failure-and-mortality-in-patients/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)

## Researcher university

- [China Medical University](https://scholariq.org/institutions/china-medical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.